THROMBOCYTOPENIA IN PATIENTS WITH CANCER: MANAGING

Course overview

Thrombocytopenia is a common adverse effect of chemotherapy during treatment of patients with cancer. This continuing education module is designed to give the reader/learner an increased understanding of managing thrombocytopenia in patients with cancer, including its clinical presentation, potential complications, and treatment and to aid in caring for the patient with this diagnosis. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.